What is the Impact Factor of Pharmacotherapy?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Pharmacotherapy is 4.00, ranking in quartile Q2 of Web of Science (SCIE).

Is Pharmacotherapy indexed in Web of Science or Scopus?

Yes, Pharmacotherapy is indexed in Web of Science (SCIE, Q2 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 1.189 (Q1) and an H-index of 136.

Who publishes Pharmacotherapy and what is the Article Processing Charge (APC)?

Pharmacotherapy is published by Wiley-Blackwell. The estimated Article Processing Charge (APC) is approximately $3,377 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Pharmacotherapy?

The official ISO-4 abbreviation of Pharmacotherapy is "PHARMACOTHERAPY". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q2Scopus Q1SCImago #3,695Hybrid

Pharmacotherapy

Abbreviation (ISO):PHARMACOTHERAPY

•

Identifier (ISSN):0277-0008(Print)/1875-9114(Online)

•

Publisher:Wiley-Blackwell

Official Website Submission Portal Compare

Clarivate IF (2026)

4↑ +0.6

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Pharmacotherapy

WoS Q2

Annual Impact Factor Metric

Current (2026):4

Scopus SJR & RankScopus Q1

1.189

#3,695

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

136

136 papers with at least that number of citations each

WoS: SCIE / JCRQ2

Self-Citation Rate6.9%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

102articles/year

27.68% Gold OA•68.29% Original Research

Aims & Scope

Pharmacotherapy is devoted to publication of original research articles on all aspects of human pharmacology and review articles on drugs and drug therapy. The Editors and Editorial Board invite original research reports on pharmacokinetic, bioavailability, and drug interaction studies, clinical trials, investigations of specific pharmacological properties of drugs, and related topics.

Topics Covered (Recognized by AI)

Medicine99.9%Biology79.8%Internal medicine77.4%Chemistry52.9%Pharmacology48.4%Psychology46.8%Biochemistry44.7%Surgery44.5%Pathology44.2%Psychiatry43.5%Genetics41.1%Endocrinology34.6%Intensive care medicine27.2%Anesthesia27.1%Organic chemistry23.6%

Primary Research Areas

Medicine Pharmacy

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

PHARMACOLOGY & PHARMACY

Rank109/356

IndexSCIE

JCISCIE2026

PHARMACOLOGY & PHARMACY

Rank127/356

IndexSCIE

Category	Index	Rank	Quartile
PHARMACOLOGY & PHARMACY	JCRSCIE	109/356	Q2
PHARMACOLOGY & PHARMACY	JCISCIE	127/356	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF4

Articles / Year106

Total Citations41

2025

IF3.4

Articles / Year129

Total Citations324

2024

IF2.9

Articles / Year99

Total Citations495

2023

IF4.1

Articles / Year161

Total Citations1,795

2022

IF6.251

Articles / Year112

Total Citations1,559

Year	Impact Factor	Articles / Year	Total Citations
2026	4	106	41
2025	3.4	129	324
2024	2.9	99	495
2023	4.1	161	1,795
2022	6.251	112	1,559
2021	4.705	121	1,542
2020	3.473	147	3,806
2019	3.045	155	4,182
2018	3.196	144	4,482
2017	—	196	5,191
2016	—	213	6,546
2015	—	162	5,933

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #3,695Scopus Q1SCImago Profile

Scopus Coverage:1981-2026

•

Scopus Broad Areas:Medicine

Scopus Citation Rank (SJR)Q1

1.189

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

3.72

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,377 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,235

3-Year Documents305

Citable Documents282

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate46.4%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pharmacology (medical)Q1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 6.9%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

3区PHARMACOLOGY & PHARMACY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Pharmacotherapy (abbr: PHARMACOTHERAPY, ISSN: 0277-0008) is a peer-reviewed international scholarly journal in the field of Medicine, published by Wiley-Blackwell in United States since 1981. The periodical holds a Journal Impact Factor (JIF) of 4.00, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 1.189 (Q1), an H-index of 136.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 102 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,377 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.